Pharmacological approaches to stroke recovery

Cerebrovascular Diseases

Volumn 9, Issue SUPPL. 5, 1999, Pages 29-32

  Fisher, Marc ^a,c   Finklestein, Seth ^b  

^a University of Massachusetts Medical School   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BASIC FIBROBLAST GROWTH FACTOR; CITICOLINE; CLOMETHIAZOLE; DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; MUSCIMOL; OSTEOGENIC PROTEIN 1; TRAZODONE;

CONFERENCE PAPER; HUMAN; INTRACISTERNAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

EID: 0032825279     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047573     Document Type: Conference Paper

References (24)

1. Furie KL, Oglivy CS, Smrcka M, Suwanwela N, Can U, Ay H, Cramer SC, Greensberg SM, Rordorf G, Finklestein SP, Foster GP, Koroshetz WJ, Kistler JP: Cerebrovascular disease; in Rosenberg RN (ed): The Atlas of Clinical Neurology. Philadelphia, Current Medicine, 1998, pp 5.1-5.82.
2. Weiller C, Chollet F, Friston KJ, Wise RJ, Frackowiak RS: Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992;31:463-472.
3. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK, Kennedy DN, Finklestein SP, Rosen BR: A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 1997;28:2518-2527.
4. Nudo RJ, Wise BM, SiFuentes F, Milliken GW: Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996;272:1791-1794.
5. Jones TA, Schallert T: Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci 1997;14:2140-2152.
6. Kawamata T, Dietrich WD, Schallert T, Gotts JE, Cocke RR, Benowitz LI, Finklestein SP: Intracisternal basic fibroblast growth factor (bFGF) enhances functional recovery and upregulates the expression of a molecular marker of neuronal sprouting following cerebral infarction. Proc Natl Acad Sci USA 1997; 94:8179-8184.
7. Stroemer RP, Kent TA, Hulsebosch CE: Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 1995;26:2135-2144.
8. Kawamata T, Ren J, Chan TCK, Charette M, Finklestein SP: Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport 1998;9:1441-1445.
9. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP: Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 1996;16:542-547.
10. Fisher M, Meadows ME, Do T, Charette M, Finklestein SP: Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995;15:953-959.
11. Stroemer RP, Kent TA, Hulsebosch CE: Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 1998;29:2381-2395.
12. Crisostomo EA, Duncan PW, Propst SA, Dunson OB, Davis JA: Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988;23:94-97.
13. Wakjer-Batson D, Smith P, Curtis S, Unwin H, Grunler R: Amphetamine paired with physical therapy accelerates motor recovery after stroke. Stroke 1995;26:2254-2259.
14. Reding MJ, Solomon B, Borucki SJ: Effect of dextroamphetamine on motor recovery after stroke. Neurology 1995;45(suppl 4):A222.
15. Lyden PD, Hedges B: Protective effects of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke 1992;23:1463-1469.
16. Snape MF, Baldwin HA, Cross AJ, Green AR: The effects of clomethiazole and nimodipine on cortical infarct area after focal cerebral ischemia in the rat. Neuroscience 1993;53:837-844.
17. Schallert T, Hernandez TD, Barth NG: Recovery of function after brain damage. Severe and chronic disruption by diazepam. Brain Res 1986;379:104-111.
18. Goldstein LB, Batchar DB, Morgonlander JC, Davis SN: Influence of drugs on the recovery of sensorimotor function after stroke. J Neurol Rehabil 1990;4:137-144.
19. Lopez-Coviella I, Clark WM, Warach S, et al: CDP-choline (citicoline): Potential mechanisms of action and preliminary results in human stroke; in Goldstein LB (ed): Restorative Neurology. Futura, Armonk, 1999, pp 195-212.
20. Schabitz WR, Weber J, Takano K, Sandage BN, Locke KW, Fisher M: Effects of citicoline on infarct volume, mortality and behavioral outcome. J Neurol Sci 1996;138:21-25.
21. Clark WM, Warach SJ, Pettigrow LC, Gammans RE, Sabourjian LA: A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology 1997;49:671-678.
22. Clark WM, Williams BJ, Selzer KA, Zweifler R-A, Sabourjian LA: For the citicoline acute ischemia study group. Randomized efficacy trial of citicoline in acute ischemic stroke (abstract). Neurology 1998;29:287.
23. Boyeson MG, Harmon RL: Effects of tarzadone and desipramine on motor recovery in brain injured rats. Am J Phys Med Rehabil 1993;72:286-293.
24. Nakamura S: Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex. Neurosci Lett 1990;111:64-68.